Evotec SE Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

A sample of Evotec SE Regulatory Milestones data

Drug Name Generic Name Brand Name Company Name Expiry Geography Constraining Patent Number Constraining Patent Expiry Drug Expiry (Estimated) Highest Development Stage
Showing 3 of 10 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem Lorem Lorem Pfizer Inc Lorem XXXX Lorem Pending Lorem
RR-001 - - Rigenerand Srl EU EP2424979 Apr-2030 - Preclinical
EXS-21546 - - Evotec SE Japan JP2021526150 - Pending -
EXS-21546 - - Evotec SE United States US20210251995 - Pending -

A sample of Evotec SE Review Designation data

Drug Name Generic Name Company Name Indication Geography Designation Type Designation Status Designation Date
Showing 3 of 10 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem laborum do id aliqua dolore Lorem Pfizer Inc Lorem Lorem Lorem Lorem 16 Aug 2021
RR-001 - Rigenerand Srl Pancreatic Cancer EU Orphan Drug Designation Designated 19 Nov 2018
RR-001 - Rigenerand Srl Pancreatic Cancer United States Orphan Drug Designation Designated 22 May 2018
samuraciclib samuraciclib [INN] Carrick Therapeutics Ltd Breast Cancer;Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer);Triple-Negative Breast Cancer (TNBC) United States Fast Track Designation Designated 16 Aug 2021
Regulatory Milestones

Feature

Regulatory Milestones provides an interactive, comprehensive, and analytical view of Drug and Constraining Patent Expiry and Exclusivity for Marketed and Pipeline (till preclinical development stage) pharmaceutical drugs in the United States (US), Europe (United Kingdom, Germany, France, Italy, and Spain) and Japan.

Benefit

Regulatory Milestones provides patent information for all novel Marketed and Pipeline pharmaceutical drugs available in the US, Europe (United Kingdom, Germany, France, Italy, and Spain) and Japan.

The Drug Expiry filters include Expiry Geography and Expiry Date as well as US-specific information.

The Drug Expiry date is based on the Constraining Patent Expiry, Patent Term Extension or Supplementary Protection Certificate (depending on the regulator), Exclusivity analysis and specific information on Review Designations granted by regulators.

US-specific information includes Exclusivity Type and Paragraph IV Certification filing under the Hatch Waxman Act (Paragraph IV).

Value

Regulatory Milestones is easily accessible and features a user-friendly platform. The tool includes attributes relating to Drug Expiry and Constraining Patents as well as attributes from Drugs and Companies .

Clients can utilize Regulatory Milestones to save time and effort through accumulated expiry information from various sources and registries in a standardized comparable format.

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer